Abstract
Objective: To determine whether pyrrolidine dithiocarbamate(PDTC) enhances TNFα-induced apoptosis in cultured breast cancer cells and explore the role of NF-κB in TNFα-induced apoptosis. Methods: Human breast cancer cell lines MCF-7 and MDA-MB-435s were treated with TNFα, PDTC and combination therapy. Cell survivals were determined by MTT assay. Apoptosis was detected by TUNEL and flow cytometry. NF-κ B DNA binding activity was detected using electrophoresis mobility shift assay (EMSA). Western blots were performed to demonstrate IκBα(Inhibitor protein of nuclear factorκB) phosphorylation and degradation. Results: Cell growth was not suppressed by either TNFα(2000 U/ml or less) or PDTC alone. Both cell lines treated with TNFα (2000 U/ml) combined with PDTC(50 µmol/L) showed significant growth inhibition. PDTC inhibited TNFα-induced IκBα phosphorylation and degradation in both cell lines. EMSA showed that PDTC continuously inhibited TNFα induced NF-κ B DNA binding activity. TNFα induced apoptosis (TUNEL) was increased significantly when both cells were pretreated with PDTC, and this was confirmed by Flow cytometry. Conclusion: PDTC enhances TNFα-induced apoptosis via inhibiting IκBα phosphorylation and degradation in human breast cancer cells. NF-κ B protects against TNFα-induced apoptosis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Vassalli P. The pathophysiology of tumor necrosis factors[J]. Ann Rev Immunol 1992; 10: 411.
Vincent B, Mohamed B A, A C Hellin, et al. Nuclear factor-κ B, cancer, and apoptosis[J]. Biochem Pharmacol 2000; 60:1085–90.
Baeuerle PA, Baltimore D. NF-κ B: Ten years after[J]. Cell 1996; 87:13–20.
Rayet B, Gelinas C. Aberrant rel/nfkb genes and activity in human cancer[J]. Oncogene 1999; 18: 6938–47.
Amit S, Ben-Neriah Y. NF-κ B activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach[J]. Semin Cancer Biol 2003; 13:15–28.
Baidwin AS Jr. The transcription factor NF-κ B and human disease[J]. J Clin Invest 2001; 107:3–6.
Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer[J]. J Clin Invest 2001; 107:135–42.
Chen F, Castranova V, Shi xianglin, et al. New insights into the role of nuclear factor-κ B, a ubiquitous transcription factor in the initiation of diseases[J]. Clin Chem 1999; 45:7–17.
Tu Gang, Yao Zhenxiang, Dong Pujiang, et al. Expression of nuclear factor-κB in human breast cancer[J]. Chin J General Sug 2003; 12:348–50.
Ye J, Young HA, Ortaldo JR, et al. Identification of a DNA binding site for the nuclear factor YY1 in the human GM-CSF core promoter[J]. Nucleic Acids Res 1994; 5672–8.
Englaro W, Bahadoran P, Bertolotto C, et al. Tumor necrosis factor alpha-mediated inhibition of melanogenesis is dependent on nuclear factor kappa B activation[J]. Oncogene 1999; 18:1553–9.
Biawas DK, Martin KJ, McAlister C, et al. Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappa B activation[J]. Cancer Res 2003; 63:290–5.
Cheng QW, Lee HH and Li Y, et al. Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-κ B inhibition[J]. Oncogene 2000; 19:4936–40.
Harikrishna N, Poornima B N, Daniel A M, et al. Constitutive activation of NF-κ B during progression of breast cancer to hormone-independent growth[J]. Mol Cell Biol 1997; 17:3629–39.
Biswas DK, Dai SC, Cruz A, et al. The nuclear factor kappa B(NF-κ B): A potential therapeutic target for estrogen receptor negative breast cancers[J]. PNAS 2001; 98:10386–91.
Gunawardena K, Murray DK and Swope RE, et al. Inhibition of nuclear factor kappaB induces apoptosis following treatment with tumor necrosis factor alpha and an antioxidant in human prostate cancer cells[J]. Cancer Detect Prev 2002; 26:229–37.
Bach SP, Chinery R, O’Dwyer ST, et al. Pyrrolinedithiocarbamate increases the therapeutic index of %-fluorouracil in a mouse model[J]. Gastroenterology, 2000; 118:81–9.
Author information
Authors and Affiliations
Corresponding author
Additional information
Biography: TU Gang(1968–), male, doctor of medicine, attending physician, Chongqing University of Medical Science Sciences, majors in surgery.
Rights and permissions
About this article
Cite this article
Tu, G., Yao, Zx. Pyrrolidine dithiocarbamate inhibits NF-κB activation and enhances TNF-induced apoptosis in human breast cancer cells. Chin. J. Cancer Res. 16, 99–104 (2004). https://doi.org/10.1007/s11670-004-0005-y
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11670-004-0005-y